Release 5

This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example ConditionDefinition/example (JSON)

Patient Care Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: No defined compartments

Raw JSON (canonical form + also see JSON Format Specification)

Example of conditiondefinition

{
  "resourceType" : "ConditionDefinition",
  "id" : "example",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ConditionDefinition</b><a name=\"example\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ConditionDefinition &quot;example&quot; </p></div><p><b>url</b>: <code>http://hl7.org/fhir/ConditionDefinition/example</code></p><p><b>identifier</b>: id:\u00a0urn:oid:2.16.840.1.113883.4.642.25.1</p><p><b>name</b>: Hyperlipidemia</p><p><b>title</b>: Hyperlipidemia Status</p><p><b>status</b>: draft</p><p><b>date</b>: 2019-05-26T10:44:00+10:00</p><p><b>description</b>: Hyperlipidemia Status</p><p><b>code</b>: Hyperlipidemia (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#55822004)</span></p><p><b>hasSeverity</b>: false</p><p><b>hasBodySite</b>: false</p><p><b>hasStage</b>: false</p><p><b>definition</b>: <a href=\"https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf\">https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf</a></p><blockquote><p><b>observation</b></p><p><b>code</b>: Lipid Panel <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#24331-1 &quot;Lipid 1996 panel - Serum or Plasma&quot;)</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35200-5 &quot;Cholesterol [Moles/​volume] in Serum or Plasma&quot;)</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Triglyceride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35217-9 &quot;Triglyceride [Moles/​volume] in Serum or Plasma&quot;)</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol in HDL <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#2085-9 &quot;HDL Cholesterol&quot;)</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: LDL Chol. (Calc) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#13457-7 &quot;Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation&quot;)</span></p></blockquote><h3>Medications</h3><table class=\"grid\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Gemfibrozil <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.1.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#203151)</span></td></tr></table><h3>Plans</h3><table class=\"grid\"><tr><td>-</td><td><b>Reference</b></td></tr><tr><td>*</td><td><a href=\"broken-link.html\">http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a></td></tr></table></div>"
  },
  "url" : "http://hl7.org/fhir/ConditionDefinition/example",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.25.1"
  }],
  "name" : "Hyperlipidemia",
  "title" : "Hyperlipidemia Status",
  "status" : "draft",
  "date" : "2019-05-26T10:44:00+10:00",
  "description" : "Hyperlipidemia Status",
  "code" : {
    "coding" : [{
      "system" : "http://snomed.info/sct",
      "code" : "55822004",
      "display" : "Hyperlipidemia (disorder)"
    }]
  },
  "hasSeverity" : false,
  "hasBodySite" : false,
  "hasStage" : false,
  "definition" : ["https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"],
  "observation" : [{
    "code" : {
      "coding" : [{
        "system" : "http://loinc.org",
        "code" : "24331-1",
        "display" : "Lipid 1996 panel - Serum or Plasma"
      }],
      "text" : "Lipid Panel"
    }
  },
  {
    "code" : {
      "coding" : [{
        "system" : "http://loinc.org",
        "code" : "35200-5",
        "display" : "Cholesterol [Moles/​volume] in Serum or Plasma"
      }],
      "text" : "Cholesterol"
    }
  },
  {
    "code" : {
      "coding" : [{
        "system" : "http://loinc.org",
        "code" : "35217-9",
        "display" : "Triglyceride [Moles/​volume] in Serum or Plasma"
      }],
      "text" : "Triglyceride"
    }
  },
  {
    "code" : {
      "coding" : [{
        "system" : "http://loinc.org",
        "code" : "2085-9",
        "display" : "HDL Cholesterol"
      }],
      "text" : "Cholesterol in HDL"
    }
  },
  {
    "code" : {
      "coding" : [{
        "system" : "http://loinc.org",
        "code" : "13457-7",
        "display" : "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation"
      }],
      "text" : "LDL Chol. (Calc)"
    }
  }],
  "medication" : [{
    "code" : {
      "coding" : [{
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code" : "203151",
        "display" : "Gemfibrozil"
      }]
    }
  }],
  "plan" : [{
    "reference" : {
      "reference" : "http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"
    }
  }]
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.